Skip to main content
PeopleBio, Inc. logo

PeopleBio, Inc. — Investor Relations & Filings

Ticker · 304840 ISIN · KR7304840002 KO Manufacturing
Filings indexed 250 across all filing types
Latest filing 2025-12-19 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 304840

PeopleBio, Inc. is a biotechnology company specializing in the development and manufacturing of diagnostic products for protein misfolding diseases. The company's primary focus is on degenerative brain disorders, particularly Alzheimer's disease. It develops blood-based diagnostic kits and immunoassays designed for early detection. By providing tools for early diagnosis, PeopleBio aims to facilitate timely intervention and treatment, thereby improving patient outcomes for these conditions.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 95% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange) regarding the cancellation of a previously announced capital increase (유상증자 철회). Since this document details a change in the company's capital structure and financing plans, it falls under the 'Capital/Financing Update' category.
2025-12-19 Korean
기타주요경영사항 (제3자배정 유상증자결정 철회 및 경영권 변경 등에 관한 계약 해제)
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing from PeopleBio regarding the cancellation of a third-party capital increase (private placement) and the termination of a management control transfer agreement due to the counterparty's failure to pay. Since this involves a change in capital structure plans and corporate governance, and does not fit into specific categories like 'Share Issue' (which usually implies successful issuance) or 'M&A' (which usually implies a completed or active deal), it is best classified as a general regulatory filing (RNS) as it reports a significant corporate event.
2025-12-19 Korean
[기재정정]경영권변경등에관한계약체결
M&A Activity Classification · 95% confidence The document is a regulatory filing from a Korean company (PeopleBio) regarding the cancellation of a management control transfer agreement due to the counterparty's breach of contract. This type of disclosure regarding M&A or management control changes falls under the category of M&A Activity (TAR) as it pertains to the status of a takeover or control transfer agreement.
2025-12-19 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of holding an Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal notification of the administrative step required for the meeting. Given its nature as a regulatory notice regarding meeting preparation, it falls under the general regulatory filing category.
2025-12-16 Korean
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from a Korean company (PeopleBio) regarding the 'Adjustment of Conversion Price' for convertible bonds. This type of filing details changes to the capital structure, specifically the conversion price of debt instruments into equity. According to the provided filing categories, 'Capital/Financing Update' (CAP) is the most appropriate classification for updates on financing activities and capital structure changes, including adjustments to convertible securities.
2025-09-12 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'PeopleBio' covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial information, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.